Dendritic cells (DC) are a promising cell type for cancer vaccines due to their high immunostimulatory capacity. However. improper maturation of DC prior to treatment may account for the limited efficacy of DC vaccine clinical trials. Latent Membrane Protein-1 (LMP1) of Epstein-Barr virus was examined for its ability to mature and activate DC as a gene-based molecular adjuvant for DC ... https://foldlyers.shop/product-category/electric-knives/